2,4,4'-trihydroxydeoxybenzoin

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

2,4,4'-trihydroxydeoxybenzoin: structure in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID Source	ID
PubMed CID	640096
CHEMBL ID	193200
SCHEMBL ID	312243
MeSH ID	M0550320

Synonyms (29)

Synonym
OPREA1_494118
ethanone, 1-(2,4-dihydroxyphenyl)-2-(4-hydroxyphenyl)-
inchi=1/c14h12o4/c15-10-3-1-9(2-4-10)7-13(17)12-6-5-11(16)8-14(12)18/h1-6,8,15-16,18h,7h
1-(2,4-dihydroxyphenyl)-2-(4-hydroxyphenyl)ethanone
AKOS000273551
2,4,4''-terthydroxydeoxybenzoin
2,4,4''-trihydroxydeoxybenzoin
1-(2,4-dihydroxy-phenyl)-2-(4-hydroxy-phenyl)-ethanone
bdbm50166034
2,4,4'-trihydroxydeoxybenzoin
2,4,4'-terthydroxydeoxybenzoin
CHEMBL193200 ,
17720-60-4
AM62685
1-(2,4-dihydroxyphenyl)-2-(4-hydroxyphenyl)ethan-1-one
1-(2,4-dihydroxy-phenyl)2 (4-hydro xy-phenyl)-ethanone
RB3225
1-(2,4-dihydroxyphenyl)-2-(4-hydroxyphenyl)-ethanone
KLFCJXAPIFIIFR-UHFFFAOYSA-N
SCHEMBL312243
423150-69-0
CS-0098071
FT-0696422
mfcd00498162
DTXSID00348696
1-(2,4-dihydroxyphenyl)-2-(4-hydroxyphenyl)ethanone, aldrichcpr
AS-54430
1-(2,4-dihydroxy-phenyl)-2-(4-hydroxy-phenyl)ethanone
SY023840

[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Protein Targets (4)

Inhibition Measurements

Protein	Taxonomy	Measurement	Average	Min (ref.)	Avg (ref.)	Max (ref.)	Bioassay(s)
Polyphenol oxidase 2	Agaricus bisporus	IC50 (µMol)	162.2600	0.0340	3.9871	10.0000	AID427670; AID427671; AID427672
Sex hormone-binding globulin	Homo sapiens (human)	IC50 (µMol)	13.6000	0.0038	0.0038	0.0038	AID241522
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Activation Measurements

Protein	Taxonomy	Measurement	Average	Min (ref.)	Avg (ref.)	Max (ref.)	Bioassay(s)
Estrogen receptor	Homo sapiens (human)	EC50 (µMol)	2.0300	0.0000	0.5305	4.4000	AID747468
Estrogen receptor beta	Homo sapiens (human)	EC50 (µMol)	0.5000	0.0000	0.4795	4.8900	AID747467
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Biological Processes (44)

Process	via Protein(s)	Taxonomy
positive regulation of transcription by RNA polymerase II	Estrogen receptor	Homo sapiens (human)
negative regulation of transcription by RNA polymerase II	Estrogen receptor	Homo sapiens (human)
antral ovarian follicle growth	Estrogen receptor	Homo sapiens (human)
epithelial cell development	Estrogen receptor	Homo sapiens (human)
chromatin remodeling	Estrogen receptor	Homo sapiens (human)
regulation of DNA-templated transcription	Estrogen receptor	Homo sapiens (human)
signal transduction	Estrogen receptor	Homo sapiens (human)
phospholipase C-activating G protein-coupled receptor signaling pathway	Estrogen receptor	Homo sapiens (human)
positive regulation of cytosolic calcium ion concentration	Estrogen receptor	Homo sapiens (human)
androgen metabolic process	Estrogen receptor	Homo sapiens (human)
male gonad development	Estrogen receptor	Homo sapiens (human)
negative regulation of gene expression	Estrogen receptor	Homo sapiens (human)
positive regulation of phospholipase C activity	Estrogen receptor	Homo sapiens (human)
intracellular steroid hormone receptor signaling pathway	Estrogen receptor	Homo sapiens (human)
intracellular estrogen receptor signaling pathway	Estrogen receptor	Homo sapiens (human)
response to estradiol	Estrogen receptor	Homo sapiens (human)
regulation of toll-like receptor signaling pathway	Estrogen receptor	Homo sapiens (human)
negative regulation of smooth muscle cell apoptotic process	Estrogen receptor	Homo sapiens (human)
negative regulation of canonical NF-kappaB signal transduction	Estrogen receptor	Homo sapiens (human)
negative regulation of DNA-binding transcription factor activity	Estrogen receptor	Homo sapiens (human)
response to estrogen	Estrogen receptor	Homo sapiens (human)
positive regulation of DNA-templated transcription	Estrogen receptor	Homo sapiens (human)
positive regulation of transcription by RNA polymerase II	Estrogen receptor	Homo sapiens (human)
fibroblast proliferation	Estrogen receptor	Homo sapiens (human)
positive regulation of fibroblast proliferation	Estrogen receptor	Homo sapiens (human)
stem cell differentiation	Estrogen receptor	Homo sapiens (human)
regulation of inflammatory response	Estrogen receptor	Homo sapiens (human)
positive regulation of DNA-binding transcription factor activity	Estrogen receptor	Homo sapiens (human)
RNA polymerase II preinitiation complex assembly	Estrogen receptor	Homo sapiens (human)
uterus development	Estrogen receptor	Homo sapiens (human)
vagina development	Estrogen receptor	Homo sapiens (human)
prostate epithelial cord elongation	Estrogen receptor	Homo sapiens (human)
prostate epithelial cord arborization involved in prostate glandular acinus morphogenesis	Estrogen receptor	Homo sapiens (human)
regulation of branching involved in prostate gland morphogenesis	Estrogen receptor	Homo sapiens (human)
mammary gland branching involved in pregnancy	Estrogen receptor	Homo sapiens (human)
mammary gland alveolus development	Estrogen receptor	Homo sapiens (human)
epithelial cell proliferation involved in mammary gland duct elongation	Estrogen receptor	Homo sapiens (human)
protein localization to chromatin	Estrogen receptor	Homo sapiens (human)
cellular response to estradiol stimulus	Estrogen receptor	Homo sapiens (human)
negative regulation of miRNA transcription	Estrogen receptor	Homo sapiens (human)
regulation of epithelial cell apoptotic process	Estrogen receptor	Homo sapiens (human)
regulation of transcription by RNA polymerase II	Estrogen receptor	Homo sapiens (human)
cellular response to estrogen stimulus	Estrogen receptor	Homo sapiens (human)
negative regulation of transcription by RNA polymerase II	Estrogen receptor beta	Homo sapiens (human)
regulation of DNA-templated transcription	Estrogen receptor beta	Homo sapiens (human)
signal transduction	Estrogen receptor beta	Homo sapiens (human)
cell-cell signaling	Estrogen receptor beta	Homo sapiens (human)
negative regulation of cell growth	Estrogen receptor beta	Homo sapiens (human)
intracellular estrogen receptor signaling pathway	Estrogen receptor beta	Homo sapiens (human)
positive regulation of DNA-templated transcription	Estrogen receptor beta	Homo sapiens (human)
positive regulation of DNA-binding transcription factor activity	Estrogen receptor beta	Homo sapiens (human)
cellular response to estradiol stimulus	Estrogen receptor beta	Homo sapiens (human)
regulation of transcription by RNA polymerase II	Estrogen receptor beta	Homo sapiens (human)
cellular response to estrogen stimulus	Estrogen receptor beta	Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Molecular Functions (30)

Process	via Protein(s)	Taxonomy
RNA polymerase II cis-regulatory region sequence-specific DNA binding	Estrogen receptor	Homo sapiens (human)
DNA-binding transcription factor activity, RNA polymerase II-specific	Estrogen receptor	Homo sapiens (human)
TFIIB-class transcription factor binding	Estrogen receptor	Homo sapiens (human)
transcription coregulator binding	Estrogen receptor	Homo sapiens (human)
transcription corepressor binding	Estrogen receptor	Homo sapiens (human)
transcription coactivator binding	Estrogen receptor	Homo sapiens (human)
DNA-binding transcription activator activity, RNA polymerase II-specific	Estrogen receptor	Homo sapiens (human)
chromatin binding	Estrogen receptor	Homo sapiens (human)
DNA-binding transcription factor activity	Estrogen receptor	Homo sapiens (human)
nuclear receptor activity	Estrogen receptor	Homo sapiens (human)
steroid binding	Estrogen receptor	Homo sapiens (human)
protein binding	Estrogen receptor	Homo sapiens (human)
calmodulin binding	Estrogen receptor	Homo sapiens (human)
beta-catenin binding	Estrogen receptor	Homo sapiens (human)
zinc ion binding	Estrogen receptor	Homo sapiens (human)
TBP-class protein binding	Estrogen receptor	Homo sapiens (human)
enzyme binding	Estrogen receptor	Homo sapiens (human)
protein kinase binding	Estrogen receptor	Homo sapiens (human)
nitric-oxide synthase regulator activity	Estrogen receptor	Homo sapiens (human)
nuclear estrogen receptor activity	Estrogen receptor	Homo sapiens (human)
nuclear estrogen receptor binding	Estrogen receptor	Homo sapiens (human)
estrogen response element binding	Estrogen receptor	Homo sapiens (human)
identical protein binding	Estrogen receptor	Homo sapiens (human)
ATPase binding	Estrogen receptor	Homo sapiens (human)
14-3-3 protein binding	Estrogen receptor	Homo sapiens (human)
sequence-specific double-stranded DNA binding	Estrogen receptor	Homo sapiens (human)
androgen binding	Sex hormone-binding globulin	Homo sapiens (human)
protein binding	Sex hormone-binding globulin	Homo sapiens (human)
steroid binding	Sex hormone-binding globulin	Homo sapiens (human)
RNA polymerase II cis-regulatory region sequence-specific DNA binding	Estrogen receptor beta	Homo sapiens (human)
DNA-binding transcription factor activity, RNA polymerase II-specific	Estrogen receptor beta	Homo sapiens (human)
DNA binding	Estrogen receptor beta	Homo sapiens (human)
nuclear steroid receptor activity	Estrogen receptor beta	Homo sapiens (human)
nuclear receptor activity	Estrogen receptor beta	Homo sapiens (human)
steroid binding	Estrogen receptor beta	Homo sapiens (human)
protein binding	Estrogen receptor beta	Homo sapiens (human)
zinc ion binding	Estrogen receptor beta	Homo sapiens (human)
enzyme binding	Estrogen receptor beta	Homo sapiens (human)
nuclear estrogen receptor activity	Estrogen receptor beta	Homo sapiens (human)
estrogen response element binding	Estrogen receptor beta	Homo sapiens (human)
receptor antagonist activity	Estrogen receptor beta	Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Ceullar Components (15)

Process	via Protein(s)	Taxonomy
nucleus	Estrogen receptor	Homo sapiens (human)
nucleoplasm	Estrogen receptor	Homo sapiens (human)
transcription regulator complex	Estrogen receptor	Homo sapiens (human)
cytoplasm	Estrogen receptor	Homo sapiens (human)
Golgi apparatus	Estrogen receptor	Homo sapiens (human)
cytosol	Estrogen receptor	Homo sapiens (human)
plasma membrane	Estrogen receptor	Homo sapiens (human)
membrane	Estrogen receptor	Homo sapiens (human)
chromatin	Estrogen receptor	Homo sapiens (human)
euchromatin	Estrogen receptor	Homo sapiens (human)
protein-containing complex	Estrogen receptor	Homo sapiens (human)
nucleus	Estrogen receptor	Homo sapiens (human)
extracellular region	Sex hormone-binding globulin	Homo sapiens (human)
extracellular exosome	Sex hormone-binding globulin	Homo sapiens (human)
nucleus	Estrogen receptor beta	Homo sapiens (human)
nucleoplasm	Estrogen receptor beta	Homo sapiens (human)
mitochondrion	Estrogen receptor beta	Homo sapiens (human)
intracellular membrane-bounded organelle	Estrogen receptor beta	Homo sapiens (human)
chromatin	Estrogen receptor beta	Homo sapiens (human)
nucleus	Estrogen receptor beta	Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Bioassays (18)

Assay ID	Title	Year	Journal	Article
AID715002	Inhibition of mushroom tyrosinase using L-DOPA as substrate at 100 ug/ml after 10 mins	2012	Bioorganic & medicinal chemistry letters, Sep-01, Volume: 22, Issue:17	Design, synthesis and molecular simulation studies of dihydrostilbene derivatives as potent tyrosinase inhibitors.
AID241522	Inhibitory concentration against [3H]-DHT binding to human sex hormone-binding globulin (SHBG)	2005	Journal of medicinal chemistry, May-05, Volume: 48, Issue:9	Successful in silico discovery of novel nonsteroidal ligands for human sex hormone binding globulin.
AID427661	Antioxidant activity assessed as inhibition of FeCl2-induced lipid peroxidation by thiocyanate method	2009	Bioorganic & medicinal chemistry, Jul-01, Volume: 17, Issue:13	Potential antioxidants and tyrosinase inhibitors from synthetic polyphenolic deoxybenzoins.
AID295603	Inhibition of Helicobacter pylori ATCC 43504 urease at 400 ug/mL after 3 hrs pre-incubation	2007	Bioorganic & medicinal chemistry, Jun-01, Volume: 15, Issue:11	Polyphenols based on isoflavones as inhibitors of Helicobacter pylori urease.
AID243453	In vitro inhibition of [3H]DHT binding to human sex hormone-binding globulin (SHBG)	2005	Journal of medicinal chemistry, May-05, Volume: 48, Issue:9	Successful in silico discovery of novel nonsteroidal ligands for human sex hormone binding globulin.
AID427670	Inhibition of mushroom tyrosinase activity after 30 mins by spectrophotometry	2009	Bioorganic & medicinal chemistry, Jul-01, Volume: 17, Issue:13	Potential antioxidants and tyrosinase inhibitors from synthetic polyphenolic deoxybenzoins.
AID747467	Agonist activity at human estrogen receptor-beta by yeast two-hybrid assay in presence of SRC1	2013	Bioorganic & medicinal chemistry letters, Jun-01, Volume: 23, Issue:11	Discovery of natural estrogen receptor modulators with structure-based virtual screening.
AID427666	Antioxidant activity assessed as superoxide anion radical scavenging activity by spectrophotometry	2009	Bioorganic & medicinal chemistry, Jul-01, Volume: 17, Issue:13	Potential antioxidants and tyrosinase inhibitors from synthetic polyphenolic deoxybenzoins.
AID427663	Antioxidant activity assessed as potassium ferric cyanide ion reducing power after 10 mins by Oyaizu method	2009	Bioorganic & medicinal chemistry, Jul-01, Volume: 17, Issue:13	Potential antioxidants and tyrosinase inhibitors from synthetic polyphenolic deoxybenzoins.
AID747468	Agonist activity at human estrogen receptor-alpha by yeast two-hybrid assay in presence of SRC1	2013	Bioorganic & medicinal chemistry letters, Jun-01, Volume: 23, Issue:11	Discovery of natural estrogen receptor modulators with structure-based virtual screening.
AID427671	Inhibition of mushroom tyrosinase activity after 90 mins by spectrophotometry	2009	Bioorganic & medicinal chemistry, Jul-01, Volume: 17, Issue:13	Potential antioxidants and tyrosinase inhibitors from synthetic polyphenolic deoxybenzoins.
AID239833	Relative binding affinity towards human sex hormone-binding globulin (SHBG) compared to estradiol	2005	Journal of medicinal chemistry, May-05, Volume: 48, Issue:9	Successful in silico discovery of novel nonsteroidal ligands for human sex hormone binding globulin.
AID238101	Association rate constant for human sex hormone-binding globulin (SHBG)	2005	Journal of medicinal chemistry, May-05, Volume: 48, Issue:9	Successful in silico discovery of novel nonsteroidal ligands for human sex hormone binding globulin.
AID427665	Antioxidant activity assessed as DPPH radical scavenging activity incubated at 40 degC in dark after 30 mins	2009	Bioorganic & medicinal chemistry, Jul-01, Volume: 17, Issue:13	Potential antioxidants and tyrosinase inhibitors from synthetic polyphenolic deoxybenzoins.
AID427662	Antioxidant activity assessed as ferrous ion chelating effect after 10 mins	2009	Bioorganic & medicinal chemistry, Jul-01, Volume: 17, Issue:13	Potential antioxidants and tyrosinase inhibitors from synthetic polyphenolic deoxybenzoins.
AID427664	Antioxidant activity assessed as ABTS radical scavenging activity	2009	Bioorganic & medicinal chemistry, Jul-01, Volume: 17, Issue:13	Potential antioxidants and tyrosinase inhibitors from synthetic polyphenolic deoxybenzoins.
AID239836	Relative binding affinity for human sex hormone-binding globulin (SHBG) compared to testosterone	2005	Journal of medicinal chemistry, May-05, Volume: 48, Issue:9	Successful in silico discovery of novel nonsteroidal ligands for human sex hormone binding globulin.
AID427672	Inhibition of mushroom tyrosinase activity after 150 mins by spectrophotometry	2009	Bioorganic & medicinal chemistry, Jul-01, Volume: 17, Issue:13	Potential antioxidants and tyrosinase inhibitors from synthetic polyphenolic deoxybenzoins.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (6)

Timeframe	Studies, This Drug (%)	All Drugs %
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	3 (50.00)	29.6817
2010's	3 (50.00)	24.3611
2020's	0 (0.00)	2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 12.43

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

Metric	This Compound (vs All)
Research Demand Index	12.43 (24.57)
Research Supply Index	1.95 (2.92)
Research Growth Index	4.37 (4.65)
Search Engine Demand Index	0.00 (26.88)
Search Engine Supply Index	0.00 (0.95)

This Compound (12.43)

All Compounds (24.57)

Study Types

Publication Type	This drug (%)	All Drugs (%)
Trials	0 (0.00%)	5.53%
Reviews	0 (0.00%)	6.00%
Case Studies	0 (0.00%)	4.05%
Observational	0 (0.00%)	0.25%
Other	6 (100.00%)	84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Substance	Relationship Strength	Studies	Classes	Roles
gallic acid gallate : A trihydroxybenzoate that is the conjugate base of gallic acid.	2.07	1	trihydroxybenzoic acid	antineoplastic agent; antioxidant; apoptosis inducer; astringent; cyclooxygenase 2 inhibitor; EC 1.13.11.33 (arachidonate 15-lipoxygenase) inhibitor; geroprotector; human xenobiotic metabolite; plant metabolite
acetohydroxamic acid acetohydroxamic acid: urease inhibitor. oxime : Compounds of structure R2C=NOH derived from condensation of aldehydes or ketones with hydroxylamine. Oximes from aldehydes may be called aldoximes; those from ketones may be called ketoximes.. N-hydroxyacetimidic acid : A carbohydroximic acid consisting of acetimidic acid having a hydroxy group attached to the imide nitrogen.. acetohydroxamic acid : A member of the class of acetohydroxamic acids that is acetamide in which one of the amino hydrogens has been replaced by a hydroxy group.	2.03	1	acetohydroxamic acids; carbohydroximic acid	algal metabolite; EC 3.5.1.5 (urease) inhibitor
kojic acid [no description available]	2.46	2	4-pyranones; enol; primary alcohol	Aspergillus metabolite; EC 1.10.3.1 (catechol oxidase) inhibitor; EC 1.10.3.2 (laccase) inhibitor; EC 1.13.11.24 (quercetin 2,3-dioxygenase) inhibitor; EC 1.14.18.1 (tyrosinase) inhibitor; EC 1.4.3.3 (D-amino-acid oxidase) inhibitor; NF-kappaB inhibitor; skin lightening agent
edetic acid Edetic Acid: A chelating agent that sequesters a variety of polyvalent cations such as CALCIUM. It is used in pharmaceutical manufacturing and as a food additive.	2.05	1	ethylenediamine derivative; polyamino carboxylic acid; tetracarboxylic acid	anticoagulant; antidote; chelator; copper chelator; geroprotector
resacetophenone resacetophenone: structure in first source. 2',4'-dihydroxyacetophenone : A dihydroxyacetophenone that is acetophenone carrying hydroxy substituents at positions 2' and 4'.	2.03	1	dihydroxyacetophenone; resorcinols	plant metabolite
benzoin [no description available]	7.05	1	benzoins; secondary alpha-hydroxy ketone	EC 3.1.1.1 (carboxylesterase) inhibitor
ethyl-p-hydroxybenzoate ethyl-p-hydroxybenzoate: structure	2.08	1	ethyl ester; paraben	antifungal agent; antimicrobial food preservative; phytoestrogen; plant metabolite
gallacetophenone gallacetophenone: structure in first source	2.03	1	aromatic ketone
3,4-dihydroxyacetophenone 3,4-dihydroxyacetophenone: shortens action potential duration of cardiac cells. 3',4'-dihydroxyacetophenone : A dihydroxyacetophenone that is acetophenone carrying hydroxy groups at positions 3' and 4'.	2.03	1	acetophenones; catechols; dihydroxyacetophenone	metabolite
6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid [no description available]	2.05	1	chromanol; monocarboxylic acid; phenols	antioxidant; ferroptosis inhibitor; neuroprotective agent; radical scavenger; Wnt signalling inhibitor
1-(2,4-Dihydroxyphenyl)-2-(4-methoxyphenyl)ethanone [no description available]	2.74	3	stilbenoid
trans-4-coumaric acid hydroxycinnamic acid : Any member of the class of cinnamic acids carrying one or more hydroxy substituents.. trans-4-coumaric acid : The trans-isomer of 4-coumaric acid.. 4-coumaric acid : A coumaric acid in which the hydroxy substituent is located at C-4 of the phenyl ring.	2.08	1	4-coumaric acid	food component; mouse metabolite; plant metabolite
2-(3,4-dimethoxyphenyl)-1-(2,4,6-trihydroxyphenyl)ethanone [no description available]	2.05	1	stilbenoid
tamoxifen [no description available]	2.08	1	stilbenoid; tertiary amino compound	angiogenesis inhibitor; antineoplastic agent; bone density conservation agent; EC 1.2.3.1 (aldehyde oxidase) inhibitor; EC 2.7.11.13 (protein kinase C) inhibitor; estrogen antagonist; estrogen receptor antagonist; estrogen receptor modulator
3',4',7-trihydroxyisoflavone 3',4',7-trihydroxyisoflavone: from Streptomyces sp OH-1049; structure given in first source. 3',4',7-trihydroxyisoflavone : A 7-hydroxyisoflavone that is daidzein substituted by a hydroxy group at position 3'.	2.05	1	7-hydroxyisoflavones	antineoplastic agent; EC 1.3.1.22 [3-oxo-5alpha-steroid 4-dehydrogenase (NADP(+))] inhibitor; metabolite
psi-tectorigenin psi-tectorigenin: structure given in first source; isolated from Streptomyces	2.03	1
4',7,8-trihydroxyisoflavone 4',7,8-trihydroxyisoflavone: from Streptomyces sp OH-1049; structure given in first source	2.03	1	isoflavones
ascorbic acid Ascorbic Acid: A six carbon compound related to glucose. It is found naturally in citrus fruits and many vegetables. Ascorbic acid is an essential nutrient in human diets, and necessary to maintain connective tissue and bone. Its biologically active form, vitamin C, functions as a reducing agent and coenzyme in several metabolic pathways. Vitamin C is considered an antioxidant.. L-ascorbic acid : The L-enantiomer of ascorbic acid and conjugate acid of L-ascorbate.. L-ascorbate : The L-enantiomer of ascorbate and conjugate base of L-ascorbic acid, arising from selective deprotonation of the 3-hydroxy group. Required for a range of essential metabolic reactions in all animals and plants.. vitamin C : Any member of a group of vitamers that belong to the chemical structural class called butenolides that exhibit biological activity against vitamin C deficiency in animals. The vitamers include L-ascorbic acid and its salt, ionized and oxidized forms.	2.05	1	ascorbic acid; vitamin C	coenzyme; cofactor; flour treatment agent; food antioxidant; food colour retention agent; geroprotector; plant metabolite; skin lightening agent

chemdatabank.com